tinea pedis var. interdigitale
Conditions
Interventions
Product Name: Terbinafin HBF cream 1%
Pharmaceutical Form: Cream
INN or Proposed INN: terbinafini hydrochloridum
CAS Number: 78628-80-5
Concentration unit: % percent
Concentration type: equal
Concentr
Sponsors
RE&D VÚFB, s.r.o.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - outpatients (ev. inpatients), both sexes - tinea pedis var. interdigitale - age from 18 to 75 years - signed written informed consent -commitment to respect the treatment regime Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - patients younger than 18 and older than 75 years - pregnant or nursing women - allergy to cream components in anamnesis - coadministration of cytostatics, immunosupresives and corticoids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Evaluation of tolerance of Terbinafin HBF cream and comparison that of comparator.;Secondary Objective: Evaluation of efficacy of Terbinafin HBF cream and comparison that of comparator.;Primary end point(s): - number of patients clinically cured without ADRs | — |
Countries
Czech Republic
Outcome results
None listed